Skip to main content
Log in

The co-existence of Fabry and celiac diseases: a case report

  • Brief Report
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

We present a patient with Fabry disease with remarkable diagnostic findings and gluten-sensitive enteropathy. An 11-year-old girl was admitted to hospital with weight loss, anorexia, nausea, vomiting, flank pain, acroparesthesia, and painful extremities. Her mother had end-stage renal failure secondary to Fabry disease. On physical examination, she had growth retardation. Ophthalmological examination showed characteristic whorl-like corneal opacities and Fabry disease was confirmed with low α-galactosidase A (α-gal A) activity. Her painful attacks were treated with carbamazepine, but vomiting and nausea continued. Laboratory studies revealed positive serum anti-endomysium and anti-gliadin antibodies. Small intestinal biopsy showed subtotal villous atrophy compatible with gluten-sensitive enteropathy. Following treatment with a gluten-free diet, her gastrointestinal symptoms completely disappeared within a few weeks and then she had catch-up growth. In her long-term follow-up, proteinuria appeared and renal involvement was confirmed by characteristic renal biopsy findings. Following these clinicopathological findings, enzyme replacement therapy was started. In conclusion, although heterozygous females can be asymptomatic or are expected to have a mild course of the disease, a severe clinical course in our patient in the 2nd decade is of particular interest. In addition, Fabry disease occurring with gluten-sensitive enteropathy, a very rare co-existence, is emphasized.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Peters FJP, Vermeulen A, Kho Tl (2001) Anderson-Fabry disease: α-galactosidase deficiency. Lancet 357:138–140

    Article  CAS  PubMed  Google Scholar 

  2. Desnick RJ, Ioannou YA, Eng CM (2001) α-Galactosidase A deficiency: Fabry disease. In: Scriver CR, Beaudet AI, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, vol. 3, pp 3733–3774

  3. Whybra C, Kampmann C, Willers I, Davis J, Winchester B, Kreigsmann J, Brühl K, Gal A, Bunge S, Beck M (2001) Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes. J Inherited Metab Dis 24:715–724

    Article  CAS  PubMed  Google Scholar 

  4. Lyon MF (1998) X-Chromosome inactivation: a repeat hypothesis. Cytogenet Cell Genet 80:133–137

    CAS  PubMed  Google Scholar 

  5. Sheth KJ, Werlin SL, Freeman ME, Hodach AE (1981) Gastrointestinal structure and function in Fabry disease. Am J Gastroenterol 76:246–251

    CAS  PubMed  Google Scholar 

  6. Halsted CH, Rowe JW (1975) Occurrence of celiac sprue in a patient with Fabry disease. Ann Intern Med 83:524–525

    CAS  PubMed  Google Scholar 

  7. Knol IE, Ausems MG, Lindhout D, Diggelen OP van, Verwey H, Davies J, Ploos van Amstel JK, Poll-The BT (1999) Different phenotypic expression in relatives with Fabry disease caused by a W226X mutation. Am J Med Genet 82:436–439

    Article  CAS  PubMed  Google Scholar 

  8. Branton M, Schiffmann R, Kopp JB (2002) Natural history and treatment of renal involvement in Fabry disease. J Am Soc Nephrol 13:S139–S143

    PubMed  Google Scholar 

  9. Breunig F, Wanner C (2003) Enzyme replacement therapy for Fabry disease: proving the clinical benefit. Nephrol Dial Transplant 18:7–9

    Article  PubMed  Google Scholar 

  10. Schiffmann R, Kopp JB, Austin HA 3rd, Sabnis S, Moore DF, Weibel T, Balow JE, Brady RO (2001) Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA 285:2743–2749

    Article  CAS  PubMed  Google Scholar 

  11. Eng CM, Guffon N, Wilcox WR, Germain DP, Lee P, Waldek S, Caplan L, Linthorst GE, Desnick RJ (2001) Safety and efficacy of recombinant human alpha-galactosidase A-replacement therapy in Fabry disease. N Engl J Med 345:9–16

    Google Scholar 

Download references

Acknowledgement

We thank Dr. Anthony H. Fensom, Division of Medical and Molecular Genetics, UMDS, Guy’s Hospital, London, for performing the enzymatic analysis of our patient.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Leyla Tümer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tümer, L., Ezgü, F.S., Hasanoğlu, A. et al. The co-existence of Fabry and celiac diseases: a case report. Pediatr Nephrol 19, 679–681 (2004). https://doi.org/10.1007/s00467-004-1462-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-004-1462-8

Keywords

Navigation